SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-241611
Filing Date
2020-09-09
Accepted
2020-09-09 08:02:05
Documents
14
Period of Report
2020-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d19897d8k.htm   iXBRL 8-K 37352
2 EX-10.1 d19897dex101.htm EX-10.1 39680
3 EX-10.2 d19897dex102.htm EX-10.2 43914
  Complete submission text file 0001193125-20-241611.txt   274386

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20200903.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20200903_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20200903_pre.xml EX-101.PRE 11403
7 EXTRACTED XBRL INSTANCE DOCUMENT d19897d8k_htm.xml XML 3366
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 201165481
SIC: 2834 Pharmaceutical Preparations